Growth Metrics

Medpace Holdings (MEDP) Cash & Current Investments (2016 - 2026)

Medpace Holdings has reported Cash & Current Investments over the past 12 years, most recently at $652.7 million for Q1 2026.

  • Quarterly Cash & Current Investments rose 47.85% to $652.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $652.7 million through Mar 2026, up 47.85% year-over-year, with the annual reading at $497.0 million for FY2025, 25.75% down from the prior year.
  • Cash & Current Investments was $652.7 million for Q1 2026 at Medpace Holdings, up from $497.0 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $669.4 million in Q4 2024 and troughed at $28.3 million in Q4 2022.
  • The 5-year median for Cash & Current Investments is $245.4 million (2023), against an average of $281.1 million.
  • Biggest five-year swings in Cash & Current Investments: crashed 93.87% in 2022 and later surged 1205.37% in 2024.
  • Tracing MEDP's Cash & Current Investments over 5 years: stood at $28.3 million in 2022, then surged by 768.38% to $245.4 million in 2023, then surged by 172.74% to $669.4 million in 2024, then decreased by 25.75% to $497.0 million in 2025, then skyrocketed by 31.31% to $652.7 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $652.7 million, $497.0 million, and $285.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.